NQS-31688-33769
2 vaccinations
3 coded responses
23 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 482 / MI
- Registered
- 2021-06-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-23
Registered in v-safe
-
2021-06-23
Dose 1 — Pfizer-BioNTech
- 2021-06-23
-
2021-06-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-06-25
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-06-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-06-29
- 2021-06-30
- 2021-07-07
-
2021-07-14
Dose 2 — Pfizer-BioNTech
- 2021-07-14
-
2021-07-15
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal pain — Feeling: Poor · Site: Pain · Muscle or body aches, Abdominal pain · Be unable to do your normal daily activitiesFree text: Abdominal cramping at nightMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Muscle or body achesAdult check-in
- 2021-07-17
- 2021-07-18
- 2021-07-19
- 2021-07-20
- 2021-07-21
- 2021-07-28
- 2021-08-04
- 2021-08-11
- 2021-08-18
-
2021-08-25
Survey response — day 42, dose 2MedDRA: Headache — Feeling: GoodFree text: HeadachesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-15
-
2022-01-12
Survey response — 6 months, dose 2MedDRA: Dyspnoea, Headache, Nausea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Shortness of breath, nausea and headachesMedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-14
- 2022-01-19
- 2022-07-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-23 | Pfizer-BioNTech | No |
| 2 | 2021-07-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Abdominal cramping at night
Release 9 — day 42, dose 2
Symptoms: Headaches
Release 10 — 6 months, dose 2
Symptoms: Shortness of breath, nausea and headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SRO | Abdominal pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release